Your browser doesn't support javascript.
loading
Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist Treatment.
García, Ricardo A; Ito, Bruce R; Lupisella, John A; Carson, Nancy A; Hsu, Mei-Yin; Fernando, Gayani; Heroux, Madeleine; Bouvier, Michel; Dierks, Elizabeth; Kick, Ellen K; Gordon, David A; Chen, Jian; Mintier, Gabe; Carrier, Marilyn; St-Onge, Stéphane; Shah, Himanshu; Towne, Jordan; Bucardo, Marcela Sotelo; Ma, Xiuying; Ryan, Carol S; Wurtz, Nicholas R; Ostrowski, Jacek; Villarreal, Francisco J.
Affiliation
  • García RA; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Ito BR; Department of Medicine, University of California San Diego, San Diego, California.
  • Lupisella JA; Department of Medicine, University of California San Diego, San Diego, California.
  • Carson NA; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Hsu MY; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Fernando G; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Heroux M; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Bouvier M; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
  • Dierks E; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
  • Kick EK; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Gordon DA; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Chen J; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Mintier G; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Carrier M; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • St-Onge S; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
  • Shah H; Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Québec, Canada.
  • Towne J; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Bucardo MS; Department of Medicine, University of California San Diego, San Diego, California.
  • Ma X; Department of Medicine, University of California San Diego, San Diego, California.
  • Ryan CS; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Wurtz NR; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Ostrowski J; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
  • Villarreal FJ; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol-Myers Squibb Company, Pennington, New Jersey.
JACC Basic Transl Sci ; 4(8): 905-920, 2019 Dec.
Article in En | MEDLINE | ID: mdl-31909300
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: JACC Basic Transl Sci Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: JACC Basic Transl Sci Year: 2019 Type: Article